Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 1, 2019 Off

Tilray® Announces Support of Two New Clinical Research Studies in Australia and Canada

By BusinessWire

Tilray cannabis products will be used to support the Murdoch Children’s Research Institute led pilot study to evaluate the feasibility…

April 1, 2019 Off

Karuna Completes $80 Million Series B Financing

By BusinessWire

$12 million in extension funding announced Karuna awarded U.S. Patent covering lead product candidate, KarXT BOSTON–(BUSINESS WIRE)–Karuna Therapeutics, Inc. (“Karuna”)…

April 1, 2019 Off

Exicure to Present at H.C. Wainwright Global Life Sciences Conference 2019

By BusinessWire

SKOKIE, Ill.–(BUSINESS WIRE)–Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs,…

April 1, 2019 Off

Merck’s KEYTRUDA® (pembrolizumab) Approved in China for First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer (NSCLC) in Combination with Chemotherapy

By BusinessWire

KEYTRUDA is First Anti-PD-1 Therapy to be Approved in Multiple Tumor Types in China KENILWORTH, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a…

April 1, 2019 Off

Aerie Pharmaceuticals Announces Appointment of Gianluca Corbinelli as Chief Commercial Officer – Europe

By BusinessWire

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…

April 1, 2019 Off

Selumetinib Granted U.S. Breakthrough Therapy Designation in Neurofibromatosis Type 1

By BusinessWire

Designation Based on Phase 2 SPRINT Trial in Pediatric Patients with NF1 Plexiform Neurofibromas Selumetinib Is a MEK 1/2 Inhibitor…

April 1, 2019 Off

Exicure to Present at the AACR Annual Meeting 2019

By BusinessWire

Two posters are being presented at the AACR Annual Meeting in Atlanta, GeorgiaExicure’s TLR9 agonist shows activation of NK cells…

Lupin names new Independet Director
April 1, 2019 Off

Lupin names new Independet Director

By Dino Mustafić

Pharma player Lupin Limited has appointed Christine Mundkur as an Independent Director with immediate effect, the company said Monday, recent CEO of Impopharma Inc.

April 1, 2019 Off

Global Industrial Microbiological QC Market 2019-2028: Focus on Technology Trends, Application, Regulatory Framework, and Competitive Mapping Analysis and Forecasts – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Industrial Microbiological QC Market: Focus on Technology Trends, Application, Regulatory Framework, and Competitive Mapping Analysis and Forecast:…

April 1, 2019 Off

Primary Progressive Multiple Sclerosis (PPMS) – Pipeline Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Primary Progressive Multiple Sclerosis (PPMS) – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The…

Posts pagination

Previous 1 … 3,316 3,317 3,318 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine